Company Filing History:
Years Active: 2024
Title: Rick Jerome Schiebinger: Innovator in HIV Treatment
Introduction
Rick Jerome Schiebinger is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical science, particularly in the treatment of metabolic disorders associated with HIV.
Latest Patents
Rick Jerome Schiebinger holds a patent for "Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins." This invention focuses on identifying new therapeutic methods for the FGF21 polypeptide or protein, including its mutants, variants, and fusions. The patent addresses various metabolic diseases, such as insulin receptor mutation disorders, type 1 diabetes mellitus, mixed dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and other metabolic disorders. It also aims to reduce the mortality and morbidity of critically ill patients.
Career Highlights
Rick is associated with Novartis AG, a leading global healthcare company. His work has been instrumental in advancing therapeutic options for patients suffering from complex metabolic conditions.
Collaborations
Rick has collaborated with esteemed colleagues, including John Louis Diener and Jiaping Gao, to further enhance the impact of his research and innovations.
Conclusion
Rick Jerome Schiebinger's contributions to the field of HIV treatment and metabolic disorders highlight his role as a key innovator in medical science. His patent reflects a commitment to improving patient outcomes and advancing therapeutic methods.